PT - JOURNAL ARTICLE AU - Jennifer A. Goldfarb AU - Joseph D. Comber TI - Human papillomavirus (HPV) infection and vaccination: a cross-sectional study of college students’ knowledge, awareness, and attitudes in Villanova, PA AID - 10.1101/2020.12.21.20248626 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.21.20248626 4099 - http://medrxiv.org/content/early/2020/12/22/2020.12.21.20248626.short 4100 - http://medrxiv.org/content/early/2020/12/22/2020.12.21.20248626.full AB - Human papillomaviruses are major causative agents of multiple cancers including cervical, penial, and oropharyngeal cancers. Almost all sexually active individuals are exposed to HPV in their lifetime and although not all HPV subtypes are capable of causing cancers, several high-risk subtypes widely circulate. Several HPV vaccines have been developed and successfully utilized to limit the spread of these viruses and reduce rates of associated cancers. Despite their success, HPV vaccination rates remain low. Studies estimate the highest prevalence of HPV in the United States is among college students. This makes college students an ideal target for interventions that promote HPV vaccination and prevention. To this end, we were interested in investigating the relationship between low HPV vaccine uptake and attitudes and awareness about HPV vaccination among college aged students. We designed a survey to assess knowledge and perception of HPV and HPV vaccination that could help pinpoint correlations between this knowledge and vaccination status. We find that more robust education focusing on the benefits of HPV vaccination could be utilized to improve vaccination rates.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Villanova University Institutional Review Board (IRB-FY2020-62).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAggregated data available upon request. No individualized responses will be shared to protect anonymity of respondents.